Mohammad Abu Zaid (@drm_abuzaid) 's Twitter Profile
Mohammad Abu Zaid

@drm_abuzaid

Cancer doctor @IUPUI with focus on bone marrow transplant and multiple myeloma

ID: 3305815864

calendar_today01-06-2015 17:09:24

234 Tweet

227 Followers

168 Following

Mohammad Abu Zaid (@drm_abuzaid) 's Twitter Profile Photo

Our first year fellow Dr. Zach Meyer did a great job 👏🏻 presenting his study on outcomes of myeloablative thiotepa/cy conditioning in severely obese patients #Tandem23

Our first year fellow Dr. Zach Meyer did a great job 👏🏻 presenting his study on outcomes of myeloablative thiotepa/cy conditioning in severely obese patients #Tandem23
Samer Al Hadidi, MD,MS,FACP (@hadidisamer) 's Twitter Profile Photo

Help us spread the word&complete a survey to understand adoption of ICC/WHO myeloid&lymphoid neoplasm classification in 🇺🇸 ➡️can complete on your phone ✅project led by a fellow (👏) ➡️ redcap.ccf.org/redcap/surveys… #OncTwitter #HemeTwitter #AcademicTwitter #PathTwitter #hemepath

Help us spread the word&complete a survey to understand adoption of ICC/WHO myeloid&lymphoid neoplasm classification in 🇺🇸
➡️can complete on your phone 
✅project led by a fellow (👏) 
➡️ redcap.ccf.org/redcap/surveys…
#OncTwitter #HemeTwitter #AcademicTwitter #PathTwitter #hemepath
UroToday.com (@urotoday) 's Twitter Profile Photo

Maintenance oral etoposide after high-dose chemotherapy (HDCT) for patients with relapsed metastatic germ-cell tumors. #BeyondTheAbstract with Nabil Adra IU Simon Comprehensive Cancer Center. #ReadNow on UroToday > bit.ly/3zZ8Fu3 #TesticularCancer Fadi Taza, MD Dr. Rafat Abonour MD Mohammad Abu Zaid

Maintenance oral etoposide after high-dose chemotherapy (HDCT) for patients with relapsed metastatic germ-cell tumors. #BeyondTheAbstract with <a href="/nabiladra/">Nabil Adra</a> <a href="/IUCancerCenter/">IU Simon Comprehensive Cancer Center</a>. #ReadNow on UroToday &gt; bit.ly/3zZ8Fu3 #TesticularCancer <a href="/FadiTaza/">Fadi Taza, MD</a> <a href="/RafatAbonour/">Dr. Rafat Abonour MD</a> <a href="/DrM_AbuZaid/">Mohammad Abu Zaid</a>
IU Simon Comprehensive Cancer Center (@iucancercenter) 's Twitter Profile Photo

#CancerResearchDay is underway as students, fellows, and faculty at @IUPUI, Indiana University, @PUCancerCenter, and the Harper Cancer Research Institute present their current cancer research efforts. #ResearchCuresCancer

#CancerResearchDay is underway as students, fellows, and faculty at @IUPUI, <a href="/IndianaUniv/">Indiana University</a>, @PUCancerCenter, and the Harper Cancer Research Institute present their current cancer research efforts. #ResearchCuresCancer
IU Simon Comprehensive Cancer Center (@iucancercenter) 's Twitter Profile Photo

Mohammad Abu-Zaid (Mohammad Abu Zaid), MD, kicks off #CancerResearchDay as he discusses the tumor microenvironment and response to transplant in myeloma. #ResearchCuresCancer

Mohammad Abu-Zaid (<a href="/DrM_AbuZaid/">Mohammad Abu Zaid</a>), MD, kicks off #CancerResearchDay as he discusses the tumor microenvironment and response to transplant in myeloma. #ResearchCuresCancer
UroToday.com (@urotoday) 's Twitter Profile Photo

Maintenance oral etoposide after high-dose chemotherapy (HDCT) for patients with relapsed metastatic germ-cell tumors. #BeyondTheAbstract with Nabil Adra IU Simon Comprehensive Cancer Center. #ReadNow on UroToday > bit.ly/3zZ8Fu3 #TesticularCancer Fadi Taza, MD Dr. Rafat Abonour MD Mohammad Abu Zaid

Maintenance oral etoposide after high-dose chemotherapy (HDCT) for patients with relapsed metastatic germ-cell tumors. #BeyondTheAbstract with <a href="/nabiladra/">Nabil Adra</a> <a href="/IUCancerCenter/">IU Simon Comprehensive Cancer Center</a>. #ReadNow on UroToday &gt; bit.ly/3zZ8Fu3 #TesticularCancer <a href="/FadiTaza/">Fadi Taza, MD</a> <a href="/RafatAbonour/">Dr. Rafat Abonour MD</a> <a href="/DrM_AbuZaid/">Mohammad Abu Zaid</a>
AAACTT (@aaactt_org) 's Twitter Profile Photo

PTCy, Abatacept and Short Course Tacrolimus, a feasible combination for acute GVHD prevention following haploidentical PB transplantations. ‘CAST regimen’ ashpublications.org/bloodadvances/…

IU Simon Comprehensive Cancer Center (@iucancercenter) 's Twitter Profile Photo

The Indiana Myeloma Registry charts new variables of the disease in pursuit of more effective therapies. Launched in 2018, the registry will reach a pivotal milestone: a statewide enrollment of 1,000 patients. Learn more: ow.ly/3KuR50QHeHN. #MultipleMyelomaAwareness

The Indiana Myeloma Registry charts new variables of the disease in pursuit of more effective therapies. Launched in 2018, the registry will reach a pivotal milestone: a statewide enrollment of 1,000 patients. Learn more: ow.ly/3KuR50QHeHN. #MultipleMyelomaAwareness